Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...

AVeta Medical, developer of the VITA AV™ platform, today announced the appointment of Karen Noblett, M.D. as CEO. Eileen Duffy, who served as interim CEO, has been appointed Chair of the Board of ...

Monte Rosa reports interim Phase 1/2 data showing durable responses and manageable safety for MRT-2359 plus Pfizer's Xtandi ...

COVID-19 vaccines did not cause sudden deaths in young adults says a one-year AIIMS observational study Read ahead to know ...

Many of the vaginal and urinary issues women experience in midlife are interconnected-and vaginal estrogen is often ...

Hello, dear readers! Welcome to our monthly letters column. Cold weather is here, and the annual flu season is ramping up. The dominant virus this year, H3N2, is a nasty ...

When UTI is left untreated it can lead to severe complications, which include lasting kidney damage, giving birth to a low ...

Shares of Monte Rosa Therapeutics (NASDAQ:GLUE) climbed about 3.5% after the company released encouraging interim results ...

Perimenopause and menopause used to be dismissed simply as symptoms of getting older, but that’s shifting thanks to ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive topline results from an interim analysis of the Phase 3 EV-304 clinical trial ...

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Empowering social workers to discuss advance care planning with older patients with cancer could improve documentation of ...